STOCK TITAN

InspireMD to Present at Upcoming H.C. Wainwright 27th Annual Global Investment Conference

InspireMD (NASDAQ:NSPR), the developer of the CGuard® Prime carotid stent system for stroke prevention, will present at the H.C.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

InspireMD (NASDAQ:NSPR), the developer of the CGuard® Prime carotid stent system for stroke prevention, will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10th at 10:00am ET.

Investors can access both the live audio webcast and replay of the presentation through the company's website investor calendar section at inspiremd.com/investors/investor-calendar/.

Loading...
Loading translation...
Argus Aug 27 session
-1.21% close to close 0.3x rel. volume Open Argus
Details

News Market Reaction – NSPR

On Aug 27, the day this news came out, NSPR closed 1.21% below the previous close.

Data tracked by StockTitan Argus for the Aug 27 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MIAMI, Aug. 27, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to present at the upcoming H.C. Wainwright 27th Annual Global Investment Conference on Wednesday, September 10th at 10:00am Eastern Time (ET).

A live audio webcast and replay of the presentation may be accessed on the “Investor Calendar” section of the company’s website at: https://inspiremd.com/investors/investor-calendar/

About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.

Investor Contacts:
Webb Campbell
Gilmartin Group LLC
webb@gilmartinir.com
investor-relations@inspiremd.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is InspireMD (NSPR) presenting at the H.C. Wainwright Conference?

InspireMD will present at the conference on Wednesday, September 10th, 2025 at 10:00am Eastern Time (ET).

How can investors access InspireMD's H.C. Wainwright conference presentation?

Investors can access both the live audio webcast and replay through the 'Investor Calendar' section on InspireMD's website at inspiremd.com/investors/investor-calendar/.

What is InspireMD's (NSPR) main product?

InspireMD's main product is the CGuard® Prime carotid stent system, which is designed for the prevention of stroke.

What stock exchange is InspireMD (NSPR) listed on?

InspireMD (NSPR) is listed on the NASDAQ stock exchange.

Keep reading